Corixa Company

Corixa is a developer of immunotherapeutics focused on treating and preventing autoimmune diseases, cancer and infectious diseases
Technology: Whole-Cell Antigens
Industry: Whole-Cell Antigens
Headquarters: Seattle, Washington, United States
Founded Date: 1994-01-01
Employees Number: 1-10
Funding Status: M&A
Investors Number: 6
Total Funding: 15000000
Last Funding Date: 1996-01-01
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership